review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0163-7258(97)82003-7 |
P698 | PubMed publication ID | 9336022 |
P2093 | author name string | D L Montgomery | |
M A Liu | |||
J B Ulmer | |||
J J Donnelly | |||
P2860 | cites work | Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein | Q24563514 |
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations | Q24563751 | ||
Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization | Q24676991 | ||
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes | Q27860600 | ||
Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo | Q33897258 | ||
Protection against mycoplasma infection using expression-library immunization | Q34296157 | ||
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans | Q34345458 | ||
Antigen processing and presentation by the class I major histocompatibility complex | Q34389698 | ||
Runaway-replication plasmids as tools to produce large quantities of proteins from cloned genes in bacteria | Q35302873 | ||
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. | Q35778832 | ||
DNA vaccination against persistent viral infection. | Q35838136 | ||
Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin | Q35852069 | ||
Gene inoculation generates immune responses against human immunodeficiency virus type 1 | Q36284135 | ||
In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment | Q36299641 | ||
Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity | Q36366362 | ||
Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease | Q37252171 | ||
Aerosol gene delivery in vivo | Q37316567 | ||
17 A rapid alkaline extraction method for the isolation of plasmid DNA | Q70284325 | ||
Plasmid vectors as anti-viral vaccines | Q70858361 | ||
Protection against papillomavirus with a polynucleotide vaccine | Q70916613 | ||
On immunological memory | Q71284608 | ||
Humoral and cellular immunities elicited by HIV-1 vaccination | Q71876963 | ||
Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization | Q72548371 | ||
Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines | Q72641753 | ||
Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine | Q73091967 | ||
Do DNA vaccines induce autoimmune disease? | Q73106011 | ||
Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles | Q37459455 | ||
DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines | Q37495259 | ||
Hormonal modulation of a gene injected into rat heart in vivo | Q37509928 | ||
Overview of biological effects of addition of DNA molecules to cells | Q37856490 | ||
Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice | Q38566410 | ||
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. | Q40047174 | ||
An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes | Q40655841 | ||
Potential DNA vaccine integration into host cell genome | Q40937673 | ||
DNA immunization with bovine herpesvirus-1 genes | Q40937683 | ||
Particle-mediated nucleic acid immunization | Q41039359 | ||
Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes | Q41239562 | ||
Induction of Humoral and Cellular Immune Responses to the Human Immunodeficiency Type 1 Virus in Nonhuman Primates by in Vivo DNA Inoculation | Q41317048 | ||
Immune responses to nucleic acid vaccines to rabies virus | Q41337967 | ||
Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. | Q41487464 | ||
DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action | Q41493974 | ||
Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle | Q41607156 | ||
Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages | Q41930986 | ||
Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes | Q41931574 | ||
Behavior of genes directly injected into the rat heart in vivo | Q43664190 | ||
Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination | Q43809587 | ||
Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
Direct gene transfer into nonhuman primate myofibers in vivo | Q43851694 | ||
Genetic immunization is a simple method for eliciting an immune response | Q43857336 | ||
Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals | Q43876816 | ||
An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin | Q43979987 | ||
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine | Q44024302 | ||
Induction of mucosal anti-HIV antibodies by facilitated transfection of airway epithelium with lipospermine/DNA complexes | Q44079058 | ||
Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products | Q44119971 | ||
The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs | Q44420008 | ||
Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. | Q44643645 | ||
Efficient gene transfer into mammalian cells using fusogenic liposome | Q44788018 | ||
Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions | Q45217723 | ||
Persistence of plasmid DNA and expression in rat brain cells in vivo | Q45397559 | ||
Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus | Q45761525 | ||
DNA immunization against experimental genital herpes simplex virus infection | Q45771376 | ||
Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge | Q45771710 | ||
Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines | Q45783780 | ||
Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen | Q45783783 | ||
Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus | Q45788449 | ||
Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice | Q45866919 | ||
Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials | Q45866923 | ||
Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle | Q45873037 | ||
Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer | Q45877036 | ||
TAXI/UAS: A molecular switch to control expression of genes in vivo | Q45878882 | ||
Delivery of DNA-cationic liposome complexes by small-particle aerosol | Q45879687 | ||
Expression of recombinant genes in myocardium in vivo after direct injection of DNA. | Q45882882 | ||
Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice | Q46128630 | ||
Direct DNA injection into mouse tongue muscle for analysis of promoter function in vivo | Q46785300 | ||
Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. | Q54649033 | ||
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation | Q59062494 | ||
Specificity of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA | Q67685742 | ||
Strong expression of foreign genes following direct injection into fish muscle | Q68007592 | ||
Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice | Q68233229 | ||
Increased expression of DNA cointroduced with nuclear protein in adult rat liver | Q69937795 | ||
P433 | issue | 2 | |
P304 | page(s) | 195-205 | |
P577 | publication date | 1997-01-01 | |
P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
P1476 | title | DNA vaccines | |
P478 | volume | 74 |
Q37253436 | A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes |
Q46615711 | All-trans retinoic acid biases immune response induced by DNA vaccine in a Th2 direction |
Q33788131 | An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice |
Q24797438 | Antibody responses to Brugia malayi antigens induced by DNA vaccination |
Q43855252 | Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection |
Q39606099 | Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection |
Q33783789 | DNA and RNA-based vaccines: principles, progress and prospects |
Q21245503 | DNA vaccine constructs against enterovirus 71 elicit immune response in mice |
Q33923010 | DNA vaccines for viral infections: basic studies and applications |
Q33782651 | Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: the improvement of Peyer's patch targeting using a polyplex-loaded liposomes |
Q39606955 | Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. |
Q73889409 | Generation of antibodies to the urokinase receptor (uPAR) by DNA immunization of uPAR knockout mice: membrane-bound uPAR is not required for an antibody response |
Q35123357 | High-efficiency gene transfer into skeletal muscle mediated by electric pulses |
Q73028938 | Immune responses to Brugia malayi paramyosin in rodents after DNA vaccination |
Q43699664 | Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques |
Q37166275 | Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis |
Q73700055 | Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene |
Q30786522 | Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii |
Q52180788 | Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. |
Q51616212 | Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection |
Q42267194 | Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccine |
Q38426148 | Prophylactic and therapeutic DNA vaccines against Chagas disease |
Q43499223 | Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA. |
Q37248425 | Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii |
Q44108100 | Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice. |
Q36212676 | Pulmonary DNA vaccination: concepts, possibilities and perspectives |
Q33809753 | Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection |
Q36374782 | The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis |
Q77419028 | The effect of human beta2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant. Implications for peptide-based vaccines |
Q33678482 | The potential use of sperm antigens as targets for immunocontraception; past, present and future. |
Search more.